<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Physiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id><journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id><journal-title-group><journal-title>Frontiers in Physiology</journal-title></journal-title-group><issn pub-type="epub">1664-042X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28588499</article-id><article-id pub-id-type="pmc">5440563</article-id><article-id pub-id-type="doi">10.3389/fphys.2017.00310</article-id><article-categories><subj-group subj-group-type="heading"><subject>Physiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Intake of a Ketone Ester Drink during Recovery from Exercise Promotes mTORC1 Signaling but Not Glycogen Resynthesis in Human Muscle</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vandoorne</surname><given-names>Tijs</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/419364/overview"/></contrib><contrib contrib-type="author"><name><surname>De Smet</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/342721/overview"/></contrib><contrib contrib-type="author"><name><surname>Ramaekers</surname><given-names>Monique</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Van Thienen</surname><given-names>Ruud</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/338707/overview"/></contrib><contrib contrib-type="author"><name><surname>De Bock</surname><given-names>Katrien</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Clarke</surname><given-names>Kieran</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/37542/overview"/></contrib><contrib contrib-type="author"><name><surname>Hespel</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/358815/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Exercise Physiology Research Group, Department of Kinesiology, KU Leuven</institution><country>Leuven, Belgium</country></aff><aff id="aff2"><sup>2</sup><institution>Laboratory of Exercise and Health, Department of Health Sciences and Technology, ETH Zurich</institution><country>Zurich, Switzerland</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Physiology, Anatomy and Genetics, University of Oxford</institution><country>Oxford, United Kingdom</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Kimberly Huey, Drake University, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Anna Maria Giudetti, University of Salento, Italy; Christopher S. Fry, University of Texas Medical Branch, United States; Rudy Valentine, Iowa State University, United States</p></fn><corresp id="fn001">*Correspondence: Peter Hespel <email xlink:type="simple">peter.hespel@faber.kuleuven.be</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Exercise Physiology, a section of the journal Frontiers in Physiology</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>310</elocation-id><history><date date-type="received"><day>28</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>28</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Vandoorne, De Smet, Ramaekers, Van Thienen, De Bock, Clarke and Hespel.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Vandoorne, De Smet, Ramaekers, Van Thienen, De Bock, Clarke and Hespel</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><bold>Purpose:</bold> Ketone bodies are energy substrates produced by the liver during prolonged fasting or low-carbohydrate diet. The ingestion of a ketone ester (KE) rapidly increases blood ketone levels independent of nutritional status. KE has recently been shown to improve exercise performance, but whether it can also promote post-exercise muscle protein or glycogen synthesis is unknown.</p><p><bold>Methods:</bold> Eight healthy trained males participated in a randomized double-blind placebo-controlled crossover study. In each session, subjects undertook a bout of intense one-leg glycogen-depleting exercise followed by a 5-h recovery period during which they ingested a protein/carbohydrate mixture. Additionally, subjects ingested a ketone ester (KE) or an isocaloric placebo (PL).</p><p><bold>Results:</bold> KE intake did not affect muscle glycogen resynthesis, but more rapidly lowered post-exercise AMPK phosphorylation and resulted in higher mTORC1 activation, as evidenced by the higher phosphorylation of its main downstream targets S6K1 and 4E-BP1. As enhanced mTORC1 activation following KE suggests higher protein synthesis rates, we used myogenic C<sub>2</sub>C<sub>12</sub> cells to further confirm that ketone bodies increase both leucine-mediated mTORC1 activation and protein synthesis in muscle cells.</p><p><bold>Conclusion:</bold> Our results indicate that adding KE to a standard post-exercise recovery beverage enhances the post-exercise activation of mTORC1 but does not affect muscle glycogen resynthesis in young healthy volunteers. <italic>In vitro</italic>, we confirmed that ketone bodies potentiate the increase in mTORC1 activation and protein synthesis in leucine-stimulated myotubes. Whether, chronic oral KE intake during recovery from exercise can facilitate training-induced muscular adaptation and remodeling need to be further investigated.</p></abstract><kwd-group><kwd>ketone</kwd><kwd>exercise recovery</kwd><kwd>muscle</kwd><kwd>human</kwd><kwd>C2C12 myotubes</kwd><kwd>protein</kwd><kwd>glycogen</kwd><kwd>mTORC1 signaling</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Flemish Ministry of Sports, BLOSO Leerstoel Topsport Inspanningsfysiologie</funding-source></award-group><award-group><funding-source id="cn002">Fonds Wetenschappelijk Onderzoek<named-content content-type="fundref-id">10.13039/501100003130</named-content></funding-source><award-id rid="cn002">1S60116N</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="1"/><equation-count count="0"/><ref-count count="60"/><page-count count="12"/><word-count count="8414"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Skeletal muscle tissue plays a pivotal role in the regulation of whole body metabolism, functional work capacity, and exercise performance (Zurlo et al., <xref rid="B60" ref-type="bibr">1994</xref>; Egan and Zierath, <xref rid="B23" ref-type="bibr">2013</xref>). While no medicine has proven to be more efficient than exercise to improve muscle function (Booth et al., <xref rid="B9" ref-type="bibr">2000</xref>), exercise-nutrition interactions significantly impact on energy substrate replenishment and on muscle remodeling and repair post-exercise (Beelen et al., <xref rid="B4" ref-type="bibr">2010</xref>; Hawley et al., <xref rid="B30" ref-type="bibr">2011</xref>). During recovery from exercise, amino acid intake is required to stimulate muscle protein synthesis (Biolo et al., <xref rid="B6" ref-type="bibr">1997</xref>; Churchward-Venne et al., <xref rid="B14" ref-type="bibr">2012</xref>), whilst high-rate carbohydrate intake promotes resynthesis of glycogen stores (Costill et al., <xref rid="B17" ref-type="bibr">1981</xref>; Burke et al., <xref rid="B10" ref-type="bibr">2016</xref>). Furthermore, improving the (nutritional) conditions under which exercise promotes muscle protein synthesis is not only important for athletes, but also in clinical conditions requiring enhanced anabolic response in patients who are unable to perform high-intensity exercise.</p><p>Skeletal muscle protein synthesis following exercise is mainly regulated by the mechanistic target of rapamycin complex 1 (mTORC1) (Bodine et al., <xref rid="B7" ref-type="bibr">2001</xref>; Schiaffino and Mammucari, <xref rid="B51" ref-type="bibr">2011</xref>). mTORC1 regulates protein translation initiation and elongation via phosphorylation of the ribosomal protein S6 kinase 1 (S6K1) and the eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) (Burnett et al., <xref rid="B11" ref-type="bibr">1998</xref>). Muscle contractions <italic>per se</italic> activate mTORC1 in a stress and/or mechanic-related manner, but also the intake of proteins activates mTORC1 and protein synthesis (Morton et al., <xref rid="B43" ref-type="bibr">2015</xref>). On the other hand, as protein synthesis is a high ATP-consuming process, mTORC1 activity is inhibited during periods of energetic stress by the AMP-activated protein kinase (AMPK; Bolster et al., <xref rid="B8" ref-type="bibr">2002</xref>; Dreyer et al., <xref rid="B20" ref-type="bibr">2006</xref>). AMPK is the principal energy sensor in muscle cells and is activated by decreased energy levels during and after contractions (Hardie, <xref rid="B29" ref-type="bibr">2011</xref>). AMPK promotes energy substrate catabolism to generate ATP, and at the same time inhibits anabolic processes requiring ATP, in order to preserve energy status (Gwinn et al., <xref rid="B28" ref-type="bibr">2008</xref>). During and after strenuous exercise, activation of AMPK is responsible for the delayed activation of muscle protein synthesis (Dreyer et al., <xref rid="B20" ref-type="bibr">2006</xref>; Thomson et al., <xref rid="B55" ref-type="bibr">2008</xref>). Rapid restoration of muscle energy balance to de-activate AMPK is important in that it enhances post-exercise mTORC1 activation, protein synthesis and eventually training-induced muscle remodeling.</p><p>Muscle glycogen is the primary fuel for muscle contractions during high-intensity endurance exercise. Glycogen stores are small relative to the total energy need in prolonged exercise, which makes initial muscle glycogen content an important determinant of performance (Hawley et al., <xref rid="B31" ref-type="bibr">1997</xref>). Hence, maximizing muscle glycogen resynthesis is crucial for maintenance of endurance exercise performance whenever time for recovery between events is short relative to the time needed to full glycogen repletion (Burke et al., <xref rid="B10" ref-type="bibr">2016</xref>).</p><p>Acetoacetate (AcAc) and beta-hydroxybutyrate (&#x003b2;HB) are the main ketone bodies (KB) produced in the liver in response to low blood glucose and insulin levels, and play a critical role in survival during episodes of fasting. Three weeks of starvation result in blood ketone levels of up to ~6 mM (Cahill, <xref rid="B12" ref-type="bibr">2006</xref>). Alternatively, a strict ketogenic diet containing low carbohydrate, low protein, but high fat (Cahill and Veech, <xref rid="B13" ref-type="bibr">2003</xref>), can also elevate circulating KB levels to ~1&#x02013;2 mM within 2&#x02013;4 days (Pinckaers et al., <xref rid="B50" ref-type="bibr">2016</xref>). Under those conditions, KB serve as circulating energy substrates for metabolic tissues such as the brain (Kashiwaya et al., <xref rid="B36" ref-type="bibr">2010</xref>), cardiac (Nakatani et al., <xref rid="B46" ref-type="bibr">2015</xref>), and skeletal muscle (Cahill, <xref rid="B12" ref-type="bibr">2006</xref>). Mechanistically, KB fuel the tricarboxylic acid (TCA) cycle after being converted to acetyl-coenzyme A (Shi and Tu, <xref rid="B53" ref-type="bibr">2015</xref>; Murray et al., <xref rid="B44" ref-type="bibr">2016</xref>), and prevent the depletion of carbohydrate stores as well as the breakdown of muscle contractile proteins for gluconeogenesis and TCA cycle anaplerosis. While KB in this way could potentially affect performance, the dietary conditions needed to stimulate endogenous KB synthesis are not compatible with optimal performance in most sports (Cox and Clarke, <xref rid="B18" ref-type="bibr">2014</xref>). Recently, the ketone monoester (R)-3-hydroxybutyl (R)-3-hydroxybutyrate (hereafter referred to as KE) has emerged as an alternative approach to raise blood KB levels in the absence of any other dietary modification. Ingestion of KE increases blood ketone appearance within minutes of consumption (Clarke et al., <xref rid="B16" ref-type="bibr">2012b</xref>), leading to circulating concentrations similar to those observed in prolonged fasting, even in the presence of elevated blood insulin levels (Clarke et al., <xref rid="B16" ref-type="bibr">2012b</xref>; Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>). KE enhanced endurance exercise performance in athletes, at least partly because KB act as an alternative substrate for oxidative phosphorylation (Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>). Interestingly, by reducing the need for glucose-derived ATP production, KE also resulted in glycogen sparing during exercise (Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>).</p><p>Against the above background, we decided to investigate whether nutritional ketosis, induced via KE ingestion, could enhance markers of muscle protein synthesis and/or glycogen resynthesis during recovery from strenuous exercise. While ingestion of KE did not increase muscle glycogen resynthesis, it increased activation of muscle protein synthesis markers. Using an <italic>in vitro</italic> strategy, we confirmed that KB potentiated leucine-mediated mTORC1 activation and that this resulted into higher rate of leucine-mediated protein synthesis. Altogether, our data show that KE enhances mTORC1 activation during recovery from exercise but does not affect muscle glycogen resynthesis in human muscle.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><p>This work involved both a study in healthy human volunteers and a series of <italic>in vitro</italic> experiments in skeletal muscle myotubes.</p><sec><title>Study in healthy volunteers</title><sec><title>Subjects</title><p>Eight healthy, young male volunteers [height: 181.9 &#x000b1; 1.8 cm; body weight (BW): 76.6 &#x000b1; 2.7 kg; body mass index: 22.9 &#x000b1; 0.7 kg/m<sup>2</sup>; age: 20&#x02013;24 years old; one repetition maximum (1RM): 75 &#x000b1; 1.25 kg] participated in the study, which was approved by the KU Leuven Biomedical Ethics Committee (B322201316517), and conformed to the Declaration of Helsinki. All subjects were involved in regular physical activity, but none participated in elite competitive sports. Potential participants were screened using a health questionnaire and underwent a medical examination, including a resting ECG, prior to participation in this study. Subjects were instructed not to change their normal diet or physical activity level during the study, and gave their written consent after having been informed of all experimental procedures and risks associated with the experiments. During the study, one subject dropped-out due to a knee-injury that was unrelated to the study protocol. The subject was excluded from all analysis.</p></sec><sec><title>Study design (Figure <xref ref-type="fig" rid="F1">1</xref>)</title><p>The study was of a randomized, double blind, placebo-controlled crossover study design involving two experimental sessions with a 3-week washout period in between. Each experimental session consisted of a glycogen-depleting exercise protocol with the right leg, followed by a 5 h recovery period during which a high-dose protein-carbohydrate mixture was administered. In addition, in one experimental condition the subjects received a KE drink during the recovery period, whilst in the other condition they received an isocaloric PL drink (Clarke et al., <xref rid="B16" ref-type="bibr">2012b</xref>). Two weeks before the start of the study, the subjects participated in two preliminary sessions with a 1-week interval in between to become familiar with the experimental procedures and to adjust the individual exercise workloads to be used in the experimental sessions. These sessions were also used to determine the 1-repetition-maximum (1RM) for knee-extension exercise.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Schematic representation of the study design</bold>. PL, placebo; KE, ketone ester; KE, ketone ester (R)-3-hydroxybutyl (R)-3-hydroxybutyrate; CHO, carbohydrate; PROT, protein. Arrows (&#x02193;) indicate ingestion of PL or KE. Negative time points indicate before exercise; positive time points indicate after exercise.</p></caption><graphic xlink:href="fphys-08-00310-g0001"/></fig></sec><sec><title>Experimental sessions</title><p>The evening before each experimental session the subjects reported to the laboratory for a standardized dinner (18 kcal&#x000b7;kg<sup>&#x02212;1</sup> BW, 70% carbohydrates, 15% protein, 15% fat). Next morning, they received a standardized breakfast (10 kcal&#x000b7;kg<sup>&#x02212;1</sup> BW, 70% carbohydrates, 18% protein, 12% fat) and, later lunch (10 kcal&#x000b7;kg<sup>&#x02212;1</sup> BW, 70% carbohydrates, 18% protein, 12% fat). After lunch the subjects rested for 2 h in a comfortable chair before blood samples were taken from both an earlobe (capillary blood) and an arm vein (Venoject, Tokyo, Japan). A percutaneous needle biopsy for baseline determinations was then taken from m. vastus lateralis in the left leg as described below. Post-exercise biopsies later in the experiment were taken from the other leg, to limit artifacts due to multiple biopsies in the same muscle belly (Van Thienen et al., <xref rid="B57" ref-type="bibr">2014</xref>). Thereafter, warming-up was started by unilateral cycling (50-70-90 Watt, 4 min each) with the right leg on a cycle ergometer (Avantronic Cyclus II, Leipzig, Germany), followed by 2 series of 30 unilateral knee-extensions at 10% of 1RM on a self-constructed isokinetic dynamometer (Hespel et al., <xref rid="B32" ref-type="bibr">2001</xref>). The subjects then started an intermittent exercise protocol aimed to deplete muscle glycogen in the right leg by unilateral knee-extensions (70&#x000b0;&#x02013;130&#x000b0; knee-angle) at a rate of 0.5 Hz. Subjects first performed an exercise bout, during which they produced as high as possible a mean power output for 5 min. Thereafter they did 9 series of 30 knee-extensions at 30% of 1RM, followed by 5 series of 6 contractions at 70% of 1RM. The contraction series were interspersed by 30 s passive rest intervals. Immediately after the last exercise a capillary blood sample was taken from the earlobe, and a percutaneous needle biopsy was taken from m. vastus lateralis. Following this post-exercise biopsy, the subjects actively recovered by unilateral cycling for 20 min at 50 Watt (Avantronic Cyclus II, Leipzig, Germany), after which they rested in a comfortable chair in the laboratory till 5 h post-exercise. After 90 min and 5 h of recovery another needle biopsy was taken from m. vastus lateralis. During recovery capillary blood samples from the earlobe were taken at 30-min intervals, and a venous sample was collected from an arm vein at 90 min and 5 h. At the end of each experimental session, the subjects filled out a questionnaire to assess gastro-intestinal tolerance (adapted from Pfeiffer et al., <xref rid="B48" ref-type="bibr">2009</xref>). The questionnaire was organized in three sections. Upper abdominal problems (reflux, bloating, nausea, vomiting); lower abdominal problems (cramps, flatulence, abdominal pain, diarrhea); and systemic problems (dizziness, headache, muscle cramp, urge to urinate).</p></sec><sec><title>Nutritional supplementation during recovery</title><p>In order to elicit optimal rates of muscle protein and glycogen synthesis after exercise, subjects received a high-dose protein&#x02013;carbohydrate drink throughout the recovery period (Table <xref ref-type="table" rid="T1">1</xref>). These drinks (250 ml aliquots) were ingested at 30-min intervals starting immediately after exercise and delivered 1 g&#x000b7;kg<sup>&#x02212;1</sup> BW&#x000b7;h<sup>&#x02212;1</sup> carbohydrates (65% maltodextrin, 35% dextrose) plus 0.3 g&#x000b7;kg<sup>&#x02212;1</sup> BW&#x000b7;h<sup>&#x02212;1</sup> hydrolyzed whey-protein concentrate (Body&#x00026;Fit, Heerenveen, The Netherlands) yielding a total leucine intake of 12.1 &#x000b1; 0.4 g per person during the 5 h recovery period. In one session, the subjects also drank a KE supplement [&#x0003e;96% (R)-3-hydroxybutyl (R)-3-hydroxybutyrate] to elevate circulating plasma ketone concentrations (Clarke et al., <xref rid="B15" ref-type="bibr">2012a</xref>,<xref rid="B16" ref-type="bibr">b</xref>; Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>). In the other session, they received an isocaloric PL supplement containing &#x0003e;96% long chain triglycerides and which was similar to KE in taste and appearance, as described previously (Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>). Immediately after exercise, subjects received 0.5 g&#x000b7;kg<sup>&#x02212;1</sup> BW KE/PL (38 &#x000b1; 1.4 mL). Thereafter, the KE/PL was delivered at a rate of 0.25 g&#x000b7;kg<sup>&#x02212;1</sup> BW&#x000b7;h<sup>&#x02212;1</sup> (19 &#x000b1; 0.7 mL). This regimen was chosen to maintain high circulating plasma ketone concentrations throughout recovery (Clarke et al., <xref rid="B16" ref-type="bibr">2012b</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Composition of recovery beverages</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>Initial drinks</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Maintenance drinks</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3" style="background-color:#bbbdc0" rowspan="1"><bold>CARBOHYDRATES</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Maltodextrin</td><td valign="top" align="center" rowspan="1" colspan="1">35 (30&#x02013;40)</td><td valign="top" align="center" rowspan="1" colspan="1">25 (22&#x02013;29)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dextrose</td><td valign="top" align="center" rowspan="1" colspan="1">19 (16&#x02013;22)</td><td valign="top" align="center" rowspan="1" colspan="1">13 (12&#x02013;15)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">54 (47&#x02013;62)</td><td valign="top" align="center" rowspan="1" colspan="1">38 (33&#x02013;44)</td></tr><tr><td valign="top" align="left" colspan="3" style="background-color:#bbbdc0" rowspan="1"><bold>Protein</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Non-essential amino acids</td><td valign="top" align="center" rowspan="1" colspan="1">7 (6&#x02013;8)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (5&#x02013;7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Essential amino acids<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">6 (5&#x02013;7)</td><td valign="top" align="center" rowspan="1" colspan="1">5.4 (5&#x02013;6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total</td><td valign="top" align="center" rowspan="1" colspan="1">14 (11&#x02013;15)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (10&#x02013;13)</td></tr></tbody></table><table-wrap-foot><p><italic>Data are means and range (in parentheses) and represent grams of ingredients for recovery drinks, which were ingested relative to body weight. A 250 ml drink was given immediately after exercise, with maintenance drinks (250 ml) given at 30 min intervals throughout the 5 h recovery period</italic>.</p><fn id="TN1"><label>*</label><p><italic>The protein mixture administered yielded a total leucine intake of 11&#x02013;14 g during the 5 h recovery period, depending on BW</italic>.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Analysis of blood samples</title><p>Capillary blood samples were immediately assayed for blood glucose and &#x003b2;-hydroxybutyrate (Glucomen Lx plus-meter with Lx glucose or Lx &#x003b2;-ketone strips, Menarini Diagnostics, Firenze, Italy), and blood lactate concentrations (Lactate-Pro 2, Arkray, Kyoto, Japan). The detection limits for &#x003b2;-hydroxybutyrate were 0.1&#x02013;8.0 millimolar (mM). Venous blood samples were immediately centrifuged to separate plasma which was stored at &#x02212;80&#x000b0;C until assayed by ELISA for insulin concentration using a commercially available kit (catalog number: 10-1132-01, Mercodia Uppsala, Sweden).</p></sec><sec><title>Muscle biopsy procedure</title><p>Muscle biopsies were obtained immediately before and after exercise and 90 and 300 min post-exercise from the vastus lateralis of the quadriceps muscle under local anesthetic (2% xylocaine without epinephrine, 1 mL subcutaneously) using a Bergstr&#x000f6;m-type needle. After removal of visible blood and non-muscle material, the muscle biopsy was frozen in isopentane cooled in liquid nitrogen. After freezing, the muscle samples were immediately stored at &#x02212;80&#x000b0;C until later analysis.</p></sec><sec><title>Analysis of muscle samples</title><p>Muscle glycogen was measured as glucose residues after acid hydrolysis in freeze-dried muscle tissue using a standard enzymatic fluorometric assay (Lowry and Passonneau, <xref rid="B38" ref-type="bibr">1972</xref>). Western blots were performed as detailed previously (Masschelein et al., <xref rid="B42" ref-type="bibr">2014</xref>). In brief, frozen muscle tissue was homogenized with a Polytron mixer (Polytron Technologies, Taoyuan City, Taiwan) in ice-cold lysis buffer [1:10, w/v; 50 mM Tris-HCl, pH 7.0; 270 mM sucrose; 5 mM EGTA; 1 mM EDTA; 1 mM sodium orthovanadate; 50 mM glycerophosphate; 5 mM sodium pyrophosphate; 50 mM sodium fluoride; 1 mM dithiothreitol; 0.1% Triton X-100; and a complete protease inhibitor tablet (Roche Applied Science, Vilvoorde, Belgium)]. Homogenates were then centrifuged and supernatant was collected and stored immediately at &#x02212;80&#x000b0;C. The protein concentration was measured using a DC protein assay kit (Bio-Rad Laboratories, Nazareth, Belgium). Proteins (15&#x02013;45 &#x003bc;g) were separated by SDS-PAGE (8&#x02013;12% gels) and transferred to polyvinylidene difluoride membranes. Subsequently, membranes were blocked in TBS-T (tris-buffered saline with Tween-20) containing 5% non-fat milk for 1 h. The following antibodies were added and incubated overnight at 4&#x000b0;C in TBS-T containing 5% BSA (1:1,000): phospho-Akt/PKB Ser<sup>473</sup>, total Akt/PKB, phospho-AMPK Thr<sup>172</sup>, total AMPK, phospho-S6K1 Thr<sup>389</sup>, total S6K1, total 4E-BP1 (Cell Signaling, Leiden, The Netherlands). Membranes were then incubated for 1 h at room temperature in secondary antibody conjugated to horseradish peroxidase (1:5,000) in TBS-T containing 5% non-fat milk. Membranes were scanned and quantified with Gene Snap and Gene Tools software (Syngene, Cambridge, UK), respectively. Results are presented as the ratio protein of interest/total form or as the ratio phosphorylated &#x003b3; form/total signal. Values were expressed relative to the mean value of the post-exercise sample of their respective condition.</p></sec></sec><sec><title><italic>In vitro</italic> experiments in myoblasts</title><p>C<sub>2</sub>C<sub>12</sub> murine skeletal muscle myoblasts (ATCC, Manassas, US) were grown in DMEM (Life Technologies, Merelbeke, Belgium) supplemented with 10% fetal bovine serum, 50 U/ml penicillin and 50 &#x003bc;g/ml streptomycin at 37&#x000b0;C and 5% CO<sub>2</sub>. At 80% confluence, myogenic differentiation was induced by changing the growth medium to DMEM supplemented with 2% horse serum, 50 U/ml penicillin, and 50 &#x003bc;g/ml streptomycin. After 96 h of differentiation, plates were incubated for 30 min in DMEM containing 5.0 mM glucose and lacking leucine (Sigma-Aldrich, Bornem, Belgium). Next, cells were incubated with leucine (1.5 mM), 3-hydroxybutyrate/ hydroxybutyric acid (4 mM) and lithium-acetoacetate (1.4 mM), alone or in combination. Since KE has been shown to raise blood &#x003b2;HB:AcAc levels in a 4:1 ratio (Clarke et al., <xref rid="B16" ref-type="bibr">2012b</xref>), the concentrations used in our <italic>in vitro</italic> experiments closely resemble the <italic>in vivo</italic> setting. Unstimulated cells served as control. After 30 min of incubation, cells were lysed and prepared for western blotting as described above. Western blot analyses were performed for, total 4E-BP1 p-S6K1<sup>Thr389</sup> and total S6K1. Antibodies used were identical as for the <italic>in vivo</italic> experiments. In a follow-up experiment, 1 &#x003bc;M puromycin, a structural analog of tyrosyl-tRNA, was added to the wells during 30 min incubation at 5 mM leucine or 1.5 mM leucine, alone or together with 4 mM 3-hydroxybutyrate and 1.4 mM lithium-acetoacetate. Subsequently, cells were lysed and prepared for western blotting as described above. Western blot analyses were performed using an anti-puromycin antibody (Merck, Overijse, Belgium) diluted 1:25,000 in TBS-T containing 5% non-fat milk, to detect puromycin incorporation into nascent peptide chains (Goodman et al., <xref rid="B26" ref-type="bibr">2011</xref>). Results are reported as the ratio puromycine/coomassie blue. Values were presented relative to the mean value of the unstimulated condition. All experiments were repeated at least once and each experiment consisted of three technical replicates. Leucine, lithium-acetoacetate and 3-hydroxybutyrate were purchased from Sigma-Aldrich (Bornem, Belgium).</p></sec><sec><title>Statistics</title><p>Differences between mean values over time and between conditions for the study in healthy volunteers were analyzed by 2-way repeated-measures analysis of variance (GraphPad Prism, La Jolla California, USA), using time and treatment as factors. When significant, Sidak's multi comparison test was used as a <italic>post-hoc</italic> test. In the figures, <sup>*</sup> indicates significance for KE vs. PL within a time point, and # indicates significance vs. time point 0 within a treatment. A supplementary table (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1</xref>) with the complete overview of statistical analyses has been included in this manuscript. For <italic>in vitro</italic> experiments, a one-way ANOVA was performed to assess the statistical significance of differences between conditions (GraphPad Prism, La Jolla California USA). When appropriate, a Tukey <italic>t</italic>-test was used as a <italic>post-hoc</italic> test. In the figures, <sup>*</sup> indicates significance vs. leucine stimulated condition, and # indicates significance vs. unstimulated condition. A supplementary table (Supplementary Table <xref ref-type="supplementary-material" rid="SM2">2</xref>) with the complete overview of statistical analyses has been included in this manuscript.</p><p>A <italic>p</italic> &#x0003c; 0.05 was considered statistically significant. Data are presented as mean &#x000b1; SEM.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>Study in healthy volunteers</title><sec><title>Blood biochemistry</title><p><bold>Effect of KE intake on blood &#x003b2;-hydroxybutyrate (Figure <xref ref-type="fig" rid="F2">2</xref>)</bold></p><p>Blood &#x003b2;-hydroxybutyrate (&#x003b2;HB) was undetectable (&#x0003c;0.01 mM) in PL and at baseline in KE (<italic>p</italic> &#x0003c; 0.05). Within 30 min of KE intake, blood &#x003b2;HB levels increased to 2.9 &#x000b1; 0.3 mM with KE drinks every 60 min, gradually increased during the recovery period to reach a peak of 4.3 &#x000b1; 0.5 mM at 4 h (<italic>p</italic> &#x0003c; 0.05 vs. 30 min). Blood &#x003b2;HB was consistently elevated from the start to the end of the recovery period, in every subject (mean:4.2 mM; range: 3.3&#x02013;6.3 mM).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Effect of KE intake on blood &#x003b2;-hydroxybutyrate</bold>. Data points represent individual values (open symbols-dotted line) and means (filled symbols-solid line) for blood &#x003b2;HB concentration at baseline (&#x02212;80) and during the 5 h recovery period. During recovery, either PL or KE was ingested together with a high-dose protein-carbohydrate solution. Arrows (&#x02193;) indicate ingestion of PL or KE. <sup>*</sup><italic>p</italic> &#x0003c; 0.05 KE vs. PL at time points indicated; <sup>#</sup><italic>p</italic> &#x0003c; 0.05 vs. 0 min post-exercise for KE.</p></caption><graphic xlink:href="fphys-08-00310-g0002"/></fig><p><bold>Effect of nutritional ketosis on blood glucose, insulin, and lactate (Figure <xref ref-type="fig" rid="F3">3</xref>).</bold></p><p>Due to the high-dose carbohydrate intake blood glucose rapidly increased following exercise (<italic>p</italic> &#x0003c; 0.05), reaching peak levels in both experimental conditions at 1 h. After 1 h, despite carbohydrate drinks every 30 min, blood glucose gradually returned toward the baseline (<italic>p</italic> &#x0003c; 0.05) although blood glucose was consistently (~1 mM) lower in KE (<italic>p</italic> &#x0003c; 0.05) compared with PL. Nonetheless, plasma insulin concentrations were similar between KE and PL throughout the experiment. Exercise decreased plasma insulin from ~15 mU&#x000b7;l<sup>&#x02212;1</sup> at baseline to ~3 mU&#x000b7;l<sup>&#x02212;1</sup> (<italic>p</italic> &#x0003c; 0.05) immediately post-exercise, after which recovery insulin increased (<italic>p</italic> &#x0003c; 0.05) to ~25 mU&#x000b7;l<sup>&#x02212;1</sup> at both 90 and 300 min, irrespective of the experimental group. The knee-extension exercise increased blood lactate level to ~5 mM in both groups (<italic>p</italic> &#x0003c; 0.05). Following exercise, lactate values returned to baseline within 1 h.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Effect of nutritional ketosis on blood glucose, insulin, and lactate</bold>. Data are means &#x000b1; SEM (<italic>n</italic> = 7) and represent <bold>(A)</bold> blood glucose and <bold>(B)</bold> blood lactate at baseline (&#x02212;80) and during the 5 h recovery period. Insert table shows the corresponding plasma insulin concentrations. During recovery, either PL or KE was ingested together with a high-dose protein-carbohydrate solution. <sup>*</sup><italic>p</italic> &#x0003c; 0.05 KE vs. PL at time points indicated; <sup>#</sup><italic>p</italic> &#x0003c; 0.05 vs. 0 min post-exercise for both KE and PL.</p></caption><graphic xlink:href="fphys-08-00310-g0003"/></fig></sec><sec><title>Muscle biochemistry</title><p><bold>Effect of nutritional ketosis on the Akt/mTORC1 pathway (Figure <xref ref-type="fig" rid="F4">4</xref>)</bold></p><p>Upstream of mTORC1 and unaltered by KE, the phosphorylation status of Akt at Ser<sup>473</sup> was decreased by exercise (<italic>p</italic> &#x0003c; 0.05), and returned to baseline within 90 min of recovery. To assess mTORC1 activity, we assessed the phosphorylation status of P70<sup>S6k1</sup> at Thr<sup>389</sup> (p-S6K1<sup>Thr389</sup>), and the percentage of 4E-BP1 in the phosphorylated &#x003b3;-form (4E-BP1%&#x003b3;), two of its main downstream targets involved in protein synthesis. Exercise decreased 4E-BP1%&#x003b3; (<italic>p</italic> &#x0003c; 0.05), but not p-S6K1<sup>Thr389</sup>, for both KE and PL. During recovery, p-S6K1<sup><italic>Thr</italic>389</sup> and 4E-BP1%&#x003b3; gradually increased (<italic>p</italic> &#x0003c; 0.05), with the increase greater in KE than in PL. Thus, compared with PL at the end of the 5 h recovery period, p-S6K1<sup>Thr389</sup> (~2.5-fold) and 4E-BP1%&#x003b3; (~60%) were higher in KE (<italic>p</italic> &#x0003c; 0.05). Total protein contents of Akt, S6K1, and 4E-BP1 were not different between groups, nor exhibited a change across time.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Effect of nutritional ketosis on the Akt/mTORC1 pathway</bold>. Data are means &#x000b1; SEM (<italic>n</italic> = 7) for Akt <bold>(A)</bold>, 4E-BP1 <bold>(B)</bold>, and S6K1 <bold>(C)</bold> phosphorylation measured in m. vastus lateralis at baseline (&#x02212;80) and after 0, 90, and 300 min of recovery. <bold>(D)</bold> Representative blots; vertical dotted line indicates a repositioned gel lane from the same blot. During recovery, either PL or KE was ingested together with a high-dose protein-carbohydrate solution <sup>*</sup><italic>p</italic> &#x0003c; 0.05 KE vs. PL at time points indicated; <sup>#</sup><italic>p</italic> &#x0003c; 0.05, <sup>&#x02020;</sup><italic>p</italic> &#x0003c; 0.10 vs. 0 min post-exercise at conditions indicated.</p></caption><graphic xlink:href="fphys-08-00310-g0004"/></fig><p><bold>Effect of nutritional ketosis on AMPKThr172 phosphorylation (Figure <xref ref-type="fig" rid="F5">5</xref>)</bold></p><p>Exercise did not significantly increase (<italic>p</italic> = 0.08) AMPK phosphorylation at Thr<sup>172</sup> (p-AMPK<sup>Thr172</sup>). p-AMPK<sup>Thr172</sup> in KE, but not in PL, was the same as baseline within 90 min of recovery, with lower p-AMPK<sup>Thr172</sup> in KE than in PL (<italic>p</italic> &#x0003c; 0.05). At the end of the recovery period, p-AMPK<sup>Thr172</sup> was baseline for both KE and PL. Total protein content of AMPK was not different between groups, nor exhibited a change across time.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Effect of nutritional ketosis on AMPK<sup><bold>Thr172</bold></sup> phosphorylation</bold>. Data are means &#x000b1; SEM (<italic>n</italic> = 7) and represent <bold>(A)</bold> AMPK phosphorylation measured in m. vastus lateralis at baseline (&#x02212;80) and after 0, 90, and 300 min of recovery. <bold>(B)</bold> Representative blots; vertical dotted line indicates a repositioned gel lane from the same blot. During recovery, either PL or KE was ingested together with a high-dose protein-carbohydrate solution. <sup>*</sup><italic>p</italic> &#x0003c; 0.05 KE vs. PL at time points indicated; <sup>#</sup><italic>p</italic> &#x0003c; 0.05, <sup>&#x02020;</sup><italic>p</italic> &#x0003c; 0.10 vs. 0 min post-exercise at conditions indicated.</p></caption><graphic xlink:href="fphys-08-00310-g0005"/></fig><p><bold>Effect of nutritional ketosis on muscle glycogen (Figure <xref ref-type="fig" rid="F6">6</xref>)</bold></p><p>Initial muscle glycogen content was 432 &#x000b1; 35 &#x003bc;mol g<sup>&#x02212;1</sup> dry weight in PL, vs. 437 &#x000b1; 8 &#x003bc;mol g<sup>&#x02212;1</sup> dry weight in KE. Exercise depleted muscle glycogen by ~60% (<italic>p</italic> &#x0003c; 0.05) to ~170 &#x000b1; 22 and 183 &#x000b1; 21 &#x003bc;mol. g<sup>&#x02212;1</sup> dry weight in PL and KE, respectively. Post-exercise glycogen resynthesis during the 5 h recovery period returned muscle glycogen contents to ~274 &#x000b1; 23 in KE vs. 276 &#x000b1; 20 &#x003bc;mol. g-1 dry weight in PL. There were no differences between PL and KE at any time.</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>Effect of nutritional ketosis on muscle glycogen</bold>. Data are means &#x000b1; SEM (<italic>n</italic> = 7) and represent muscle glycogen content measured in m. vastus lateralis at baseline (&#x02212;80) and after 0, 90, and 300 min of recovery. During recovery, either PL or KE was ingested together with a high-dose protein-carbohydrate solution. <sup>#</sup><italic>p</italic> &#x0003c; 0.05 vs. 0 min post-exercise at conditions indicated.</p></caption><graphic xlink:href="fphys-08-00310-g0006"/></fig></sec><sec><title>Gastrointestinal tolerance</title><p>Compared with PL (6 &#x000b1; 2 out of a maximum of 32), adverse upper abdominal discomfort scored higher in KE (17 &#x000b1; 2, <italic>p</italic> &#x0003c; 0.05). Lower abdominal and systemic discomfort was similar between the groups. Due to upper abdominal discomfort in KE, four subjects did not ingest supplements beyond 4 h of recovery. Nonetheless, plasma &#x003b2;HB, blood glucose and plasma insulin levels were unaffected, i.e., values were identical between subgroups exhibiting upper abdominal discomfort vs. no symptoms.</p></sec><sec><title><italic>In vitro</italic> experiments in myoblasts</title><p><bold>Effect of ketones and leucine on 4E-BP1 and S6K1<sup>Thr389</sup> phosphorylation in myotubes (Figure <xref ref-type="fig" rid="F7">7</xref>)</bold></p><p>Leucine alone increased p-S6K1<sup>Thr389</sup> ~3-fold and 4E-BP1%&#x003b3; by 51% (p &#x0003c; 0.05). Incubation with either acetoacetate or &#x003b2;HB alone did not increase p-S6K1<sup>Thr389</sup> or 4E-BP1%&#x003b3;, but the combination of both ketone bodies increased p-S6K1<sup>Thr389</sup> ~ 3-fold and 4E-BP1%&#x003b3; by 51% (<italic>p</italic> &#x0003c; 0.05). The addition of either acetoacetate or &#x003b2;HB with leucine elevated p-S6K1<sup>Thr389</sup> 4-fold and 4E-BP1%&#x003b3; 2-fold (<italic>p</italic> &#x0003c; 0.05). Leucine + acetoacetate + &#x003b2;HB increased p-S6K1<sup>Thr389</sup> ~ 6-fold and 4E-BP1%&#x003b3; 2-fold vs baseline, more than any of the substrates alone (<italic>p</italic> &#x0003c; 0.05).</p><fig id="F7" position="float"><label>Figure 7</label><caption><p><bold>Effect of ketones and leucine on 4E-BP1 and S6K1<sup><bold>Thr389</bold></sup> phosphorylation in myotubes</bold>. Data are means &#x000b1; SEM (<italic>n</italic> = 3). Leu, leucine; AcAc, lithium-acetoacetate; &#x003b2;HB, &#x003b2;-hydroxybutyrate. <sup>*</sup><italic>p</italic> &#x0003c; 0.05 indicates significance vs. leucine stimulated condition; <sup>#</sup><italic>p</italic> &#x0003c; 0.05 indicates significance vs. unstimulated condition.</p></caption><graphic xlink:href="fphys-08-00310-g0007"/></fig><p><bold>Effect of ketones and leucine on protein synthesis in myotubes (Figure <xref ref-type="fig" rid="F8">8</xref>)</bold></p><p>Leucine (1.5 mM) alone did not alter protein synthesis rate as measured by puromycin incorporation into nascent peptide chains (Goodman et al., <xref rid="B26" ref-type="bibr">2011</xref>). However, the addition of AcAc + &#x003b2;HB enhanced protein synthesis ~2-fold (<italic>p</italic> &#x0003c; 0.05). A supraphysiological leucine concentration (5.0 mM) was found to stimulate protein synthesis 2.5-fold (<italic>p</italic> &#x0003c; 0.05).</p><fig id="F8" position="float"><label>Figure 8</label><caption><p><bold>Effect of ketones and leucine on muscle protein synthesis in myotubes</bold>. Data are means &#x000b1; SEM (<italic>n</italic> = 3). <bold>(A)</bold> Representative image of western blot analysis for puromycin (left) followed by coomassie blue staining (right) to verify equal loading of proteins. <bold>(B)</bold> Quantification of the puromycin-labeled peptides corrected for coomassie blue staining. Leu, leucine; AcAc, lithium-acetoacetate; &#x003b2;HB, &#x003b2;-hydroxybutyrate. <sup>*</sup><italic>p</italic> &#x0003c; 0.05 indicates significance vs. leucine stimulated condition; <sup>#</sup><italic>p</italic> &#x0003c; 0.05 indicates significance vs. unstimulated condition.</p></caption><graphic xlink:href="fphys-08-00310-g0008"/></fig></sec></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>In this study, we investigated the potential of nutritional ketosis to stimulate markers of post-exercise muscle protein and glycogen synthesis, since both may enhance long-term training adaptations and facilitate muscle recovery from intense exercise (Hawley et al., <xref rid="B30" ref-type="bibr">2011</xref>). We found that oral KE ingestion increased mTORC1 activation in human skeletal muscle following strenuous exercise, but left muscle glycogen resynthesis unaffected. To explore whether the increase in mTORC1 activation leads to increased protein synthesis, we subsequently performed a set of <italic>in vitro</italic> experiments using C<sub>2</sub>C<sub>12</sub> myotubes. We confirmed that ketone bodies stimulated mTORC1 activity and showed that this leads to enhanced leucine-mediated muscle protein synthesis. Taken together, our results indicate that KE enhances the anabolic response to both exercise and protein ingestion but does not affect glycogen resynthesis.</p><p>We aimed to elevate plasma ketone concentrations using intermittent (60 min) drinks of a novel oral ketone ester (Clarke et al., <xref rid="B16" ref-type="bibr">2012b</xref>) during the initial 5 h of recovery following a glycogen-depleting maximal exercise bout. In conjunction with KE, we also administered a mixture containing whey protein and carbohydrates in a quantity that is considered to elicit maximal rates of post-exercise muscle protein (Morton et al., <xref rid="B43" ref-type="bibr">2015</xref>) and glycogen synthesis (Burke et al., <xref rid="B10" ref-type="bibr">2016</xref>), because we wanted to explore whether KE could add to the recommended nutritional procedures for stimulation of muscle recovery. KE increased blood &#x003b2;HB concentration to ~3&#x02013;5 mM within 30 min after the first drink to remain elevated to the end of the recovery period in all subjects. As KE raises blood &#x003b2;HB:AcAc levels in a 4:1 ratio (Clarke et al., <xref rid="B16" ref-type="bibr">2012b</xref>) total plasma KB concentrations above 6 mM are conceivable, levels similar to those reported after several weeks of starvation (Cahill, <xref rid="B12" ref-type="bibr">2006</xref>).</p><p>We did not detect any rise in post-exercise ketone levels in the PL condition. Post-exercise ketosis is inversely correlated to liver glycogen content (Adams and Koeslag, <xref rid="B1" ref-type="bibr">1988</xref>), which in short one-leg postprandial exercise protocols is not depleted (Gonzalez et al., <xref rid="B25" ref-type="bibr">2016</xref>). In addition, post-exercise nutritional intake, causing hyperinsulinemia, also reduces endogenous ketosis (Koeslag, <xref rid="B37" ref-type="bibr">1982</xref>; Impey et al., <xref rid="B34" ref-type="bibr">2016</xref>). Therefore, in PL post-exercise ketosis is unlikely to have significantly contributed to muscle recovery.</p><p>Muscle protein synthesis following exercise is mainly controlled by mTORC1 (Bodine et al., <xref rid="B7" ref-type="bibr">2001</xref>; Schiaffino and Mammucari, <xref rid="B51" ref-type="bibr">2011</xref>). Assessment of the phosphorylation status of the mTORC1 substrates S6K1 and 4EBP1 is a reliable readout of mTORC1 activity and is closely linked to muscle hypertrophy both in humans (Terzis et al., <xref rid="B54" ref-type="bibr">2008</xref>) and mice (Baar and Esser, <xref rid="B2" ref-type="bibr">1999</xref>). Moreover, S6K1 activation is required to increase muscle force (Marabita et al., <xref rid="B41" ref-type="bibr">2016</xref>). We found the ingestion of KE to increase mTORC1 activity during recovery from exercise, as indicated by higher phosphorylation status of S6K1 and 4EBP1 (Figure <xref ref-type="fig" rid="F4">4</xref>). While evaluation of muscle protein synthesis via key proteins involved in protein translation has been shown to be a reliable procedure (Baar and Esser, <xref rid="B2" ref-type="bibr">1999</xref>; Bodine et al., <xref rid="B7" ref-type="bibr">2001</xref>; Terzis et al., <xref rid="B54" ref-type="bibr">2008</xref>; Drummond et al., <xref rid="B21" ref-type="bibr">2009</xref>), a dissociation between S6K1/4EBP-1 phosphorylation and muscle protein synthesis might still be possible (Greenhaff et al., <xref rid="B27" ref-type="bibr">2008</xref>). Since our study protocol did not allow us to assess muscle protein synthesis rates in human subjects <italic>in vivo</italic>, we decided to set up a series of <italic>in vitro</italic> experiments using C<sub>2</sub>C<sub>12</sub> myotubes. First, we confirmed that KB potentiate mTORC1 signaling following leucine stimulation (Figure <xref ref-type="fig" rid="F7">7</xref>). Subsequently, we found that the increase in mTORC1 activity was reflected by increased protein synthesis in muscle cells <italic>in vitro</italic> (Figure <xref ref-type="fig" rid="F8">8</xref>). While our <italic>in vitro</italic> data show the ability of KB to potentiate leucine-mediated protein synthesis in myotubes, further human studies using stable isotope tracers need to confirm whether or not KE can also promote muscle protein synthesis in humans.</p><p>The ability for KE to promote mTORC1 activity occurred in the absence of increased blood insulin levels and downstream insulin signaling pathway. Moreover, we could reproduce these effects using strictly controlled <italic>in vitro</italic> settings. This indicates that the effect of KE/KB is independent of growth factor signaling as well as potential other systemic effects induced by ketosis (Egan and D'Agostino, <xref rid="B22" ref-type="bibr">2016</xref>; Holdsworth et al., <xref rid="B33" ref-type="bibr">2016</xref>).</p><p>While we for the first time show that KE stimulates mTORC1 signaling post-exercise against the background of high-rate protein plus carbohydrate intake in humans, it is well established that KB modulate muscle protein metabolism during starvation. When glucose availability is low, KB replace glucose as the primary brain fuel, and therefore suppresses the need for muscle proteolysis to provide gluconeogenic precursors (Sherwin et al., <xref rid="B52" ref-type="bibr">1975</xref>; Owen, <xref rid="B47" ref-type="bibr">2005</xref>). Furthermore, hyperketonaemia induced by intravenous infusions of a ketone salt after an overnight fast, decreased leucine oxidation and increased protein synthesis in humans (Nair et al., <xref rid="B45" ref-type="bibr">1988</xref>). The direct effect of KB on protein synthesis rates in muscle has only been explored in a limited number of <italic>ex vivo</italic> studies. One study found physiological concentrations of KB without amino acids in the incubation medium not to stimulate protein synthesis in myocytes (Tischler et al., <xref rid="B56" ref-type="bibr">1982</xref>).</p><p>Another <italic>ex vivo</italic> study tested the effect of either 4 mM &#x003b2;HB or 4 mM AcAc in chicken muscles and reported a decrease in protein synthesis. However, raising glutamine availability restored protein synthesis (Wu and Thompson, <xref rid="B59" ref-type="bibr">1990</xref>). By analogy, our results show a synergistic effect of physiological concentrations of ketone bodies and leucine on S6K1 phosphorylation (Figure <xref ref-type="fig" rid="F7">7</xref>) and a direct effect of ketone bodies on leucine-mediated protein synthesis (Figure <xref ref-type="fig" rid="F8">8</xref>). Taken together these results indicate the potential of ketone bodies to stimulate muscle protein anabolism.</p><p>Although we are unable to identify the precise mechanism responsible for enhanced muscle protein synthesis with KE, it is known that skeletal muscle protein synthesis is reduced when energy homeostasis is impaired (Hardie, <xref rid="B29" ref-type="bibr">2011</xref>). Following high-intensity exercise, activation of AMPK is responsible for the delayed activation of muscle protein synthesis (Dreyer et al., <xref rid="B20" ref-type="bibr">2006</xref>; Thomson et al., <xref rid="B55" ref-type="bibr">2008</xref>). Rapid restoration of muscle energy balance to de-activate AMPK is therefore important to initiate post-exercise mTORC1 activation and protein synthesis. KE ingestion markedly promoted the decrease in AMPK activation early during recovery, potentially via serving as an additional energy substrate for oxidative ATP production (Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>; Murray et al., <xref rid="B44" ref-type="bibr">2016</xref>) which might allow faster recovery of energy homeostasis and facilitate mTORC1 activation.</p><p>Nutritional ketosis was recently shown to alter substrate competition during endurance exercise and to reduce glycolysis, thereby preserving glycogen availability (Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>). Early experiments in dogs and rats have shown that ketosis can stimulate muscle glucose uptake (Madison et al., <xref rid="B39" ref-type="bibr">1964</xref>) as well as glycogen storage (Maizels et al., <xref rid="B40" ref-type="bibr">1977</xref>). Furthermore, ketosis generated by either a chronic high-fat, low-carbohydrate diet (Phinney et al., <xref rid="B49" ref-type="bibr">1983</xref>) or by KB intake (Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>) decreased glycogen breakdown both at rest (Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>) and during exercise (Phinney et al., <xref rid="B49" ref-type="bibr">1983</xref>; Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>). On the other hand, inducing ketosis by adhering to a ketogenic diet did not affect glycogen repletion patterns after a 3-h run (Volek et al., <xref rid="B58" ref-type="bibr">2016</xref>). Based on these data, we hypothesized that during recovery from high-intensity exercise, KE ingestion could promote glycogen resynthesis by reducing disposal of glucose units via glycolytic breakdown. Suppression of glycolysis increases glucose-6-phosphate availability, which is a potent stimulator of the glycogen synthase enzyme (Jensen and Richter, <xref rid="B35" ref-type="bibr">2012</xref>). However, contrary to our hypothesis, we found KE not to affect glycogen resynthesis during the 5 h recovery period. These data are in apparent contradiction with the results of another study in which KE increased muscle glycogen resynthesis following glycogen-depleting exercise (Holdsworth et al., <xref rid="B33" ref-type="bibr">2016</xref>). In this study, however, CHO was delivered intravenously during a 2 h hyperglycaemic clamp. Under those conditions, KE ingestion in combination with carbohydrates resulted in 2-fold higher plasma insulin levels compared to carbohydrates alone. This was conceivably due to stimulation of pancreatic insulin secretion by high circulating plasma KB (Balasse et al., <xref rid="B3" ref-type="bibr">1970</xref>; Beylot et al., <xref rid="B5" ref-type="bibr">1986</xref>). Conversely, high-rate carbohydrate intake in conjunction with proteins in the conditions of the current study resulted in substantially higher plasma insulin levels than in the aforementioned studies due to the synergistic action of glucose and amino acids on pancreatic insulin release (Floyd et al., <xref rid="B24" ref-type="bibr">1970</xref>). In addition, plasma insulin was identical between KE and PL (Figure <xref ref-type="fig" rid="F3">3A</xref>).</p><p>In the current study, subjects ingested 1.5 g&#x000b7;kg<sup>&#x02212;1</sup> BW KE, concentrations that have been reported previously to efficiently enhance blood ketone levels over longer time periods (Clarke et al., <xref rid="B16" ref-type="bibr">2012b</xref>; Cox et al., <xref rid="B19" ref-type="bibr">2016</xref>). In agreement with these studies, intermittent ingestion of KE with a protein-carbohydrate mixture resulted in blood &#x003b2;HB levels of ~5 mM but also resulted in gastrointestinal discomfort in half of the subjects. Gastrointestinal issues have been reported before under nutritional conditions not involving concomitant high-rate protein and carbohydrate intake (Clarke et al., <xref rid="B16" ref-type="bibr">2012b</xref>). Although we cannot exclude that GI discomfort might have affected our experiment, biochemical measurements and circulating concentrations of &#x003b2;HB, glucose, and insulin were identical between subjects experiencing GI distress and subjects with adequate GI comfort. Future studies will need to elucidate more optimal dosing strategies to maintain the effect of KE on muscle protein synthesis in the absence of GI complaints.</p><p>In conclusion, while ingestion of KE did not increase muscle glycogen resynthesis, it markedly increased mTORC1 signaling following high-intensity exercise. Using C<sub>2</sub>C<sub>12</sub> myotubes, we confirmed that KB potentiated leucine mediated mTORC1 activation and that this resulted into higher leucine-mediated protein ynthesis. Our results indicate that KE enhances the anabolic response to both exercise and protein ingestion but does not affect muscle glycogen synthesis, suggesting that it might become an attractive nutritional strategy to increase training-induced muscle remodeling and adaptation.</p></sec><sec id="s5"><title>Ethics statement</title><p>The study was approved by the KU Leuven Biomedical Ethics Committee (B322201316517) and was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent after clearing medical screening and being fully informed about the content of the experiments and the risks involved.</p></sec><sec id="s6"><title>Author contributions</title><p>Conception and design of the study: PH, TV, and SD. All authors contributed to the acquisition, analysis and interpretation of the data, and revised and approved the final manuscript for important intellectual content written by TV, PH, and KD.</p></sec><sec id="s7"><title>Funding</title><p>This work was supported by the Flemish Ministry of Sport, BLOSO&#x02014;&#x0201c;Leerstoel Topsport Inspanningsfysiologie.&#x0201d; Research Fund Flanders (FWO) supports TV by an FWO-fellowship strategic basic research (1S60116N).</p><sec><title>Conflict of interest statement</title><p>The intellectual property and patents covering the use of the (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone mono-ester are owned by BTG Ltd., The University of Oxford, the NIH and TdeltaS Ltd. KC is a non-executive director of TdeltaS, a spin out company of the University of Oxford. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>We thank all participants for their participation in this study, Nicola Dixon (University of Oxford) for writing assistance and Gommaar D'Hulst (KU Leuven) for technical assistance with western blotting.</p></ack><sec sec-type="supplementary-material" id="s8"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fphys.2017.00310/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fphys.2017.00310/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Table1.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="SM2"><media xlink:href="Table2.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>J. H.</given-names></name><name><surname>Koeslag</surname><given-names>J. H.</given-names></name></person-group> (<year>1988</year>). <article-title>Carbohydrate homeostasis and post-exercise ketosis in trained and untrained rats</article-title>. <source>J. Physiol.</source>
<volume>407</volume>, <fpage>453</fpage>&#x02013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1988.sp017425</pub-id><pub-id pub-id-type="pmid">3256624</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baar</surname><given-names>K.</given-names></name><name><surname>Esser</surname><given-names>K.</given-names></name></person-group> (<year>1999</year>). <article-title>Phosphorylation of p70(S6k) correlates with increased skeletal muscle mass following resistance exercise</article-title>. <source>Am. J. Physiol.</source>
<volume>276</volume>, <fpage>C120</fpage>&#x02013;<lpage>C127</lpage>. <pub-id pub-id-type="pmid">9886927</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasse</surname><given-names>E. O.</given-names></name><name><surname>Ooms</surname><given-names>H. A.</given-names></name><name><surname>Lambilliotte</surname><given-names>J. P.</given-names></name></person-group> (<year>1970</year>). <article-title>Evidence for a stimulatory effect of ketone bodies on insulin secretion in man</article-title>. <source>Horm. Metab. Res.</source>
<volume>2</volume>, <fpage>371</fpage>&#x02013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1055/s-0028-1096822</pub-id><pub-id pub-id-type="pmid">4940073</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beelen</surname><given-names>M.</given-names></name><name><surname>Burke</surname><given-names>L. M.</given-names></name><name><surname>Gibala</surname><given-names>M. J.</given-names></name><name><surname>Jc van Loon</surname><given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Nutritional strategies to promote postexercise recovery</article-title>. <source>Int. J. Sport Nutr. Exerc. Metab.</source>
<volume>20</volume>, <fpage>515</fpage>&#x02013;<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1123/ijsnem.20.6.515</pub-id><pub-id pub-id-type="pmid">21116024</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beylot</surname><given-names>M.</given-names></name><name><surname>Khalfallah</surname><given-names>Y.</given-names></name><name><surname>Riou</surname><given-names>J. P.</given-names></name><name><surname>Cohen</surname><given-names>R.</given-names></name><name><surname>Normand</surname><given-names>S.</given-names></name><name><surname>Mornex</surname><given-names>R.</given-names></name></person-group> (<year>1986</year>). <article-title>Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man</article-title>. <source>J. Clin. Endocrinol. Metab.</source>
<volume>63</volume>, <fpage>9</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1210/jcem-63-1-9</pub-id><pub-id pub-id-type="pmid">3519651</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biolo</surname><given-names>G.</given-names></name><name><surname>Tipton</surname><given-names>K. D.</given-names></name><name><surname>Klein</surname><given-names>S.</given-names></name><name><surname>Wolfe</surname><given-names>R. R.</given-names></name></person-group> (<year>1997</year>). <article-title>An abundant supply of amino acids enhances the metabolic effect of exercise on muscle protein</article-title>. <source>Am. J. Physiol.</source>
<volume>273</volume>, <fpage>E122</fpage>&#x02013;<lpage>E129</lpage>. <pub-id pub-id-type="pmid">9252488</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodine</surname><given-names>S. C.</given-names></name><name><surname>Stitt</surname><given-names>T. N.</given-names></name><name><surname>Gonzalez</surname><given-names>M.</given-names></name><name><surname>Kline</surname><given-names>W. O.</given-names></name><name><surname>Stover</surname><given-names>G. L.</given-names></name><name><surname>Bauerlein</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy <italic>in vivo</italic></article-title>. <source>Nat. Cell Biol.</source>
<volume>3</volume>, <fpage>1014</fpage>&#x02013;<lpage>1019</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1101-1014</pub-id><pub-id pub-id-type="pmid">11715023</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolster</surname><given-names>D. R.</given-names></name><name><surname>Crozier</surname><given-names>S. J.</given-names></name><name><surname>Kimball</surname><given-names>S. R.</given-names></name><name><surname>Jefferson</surname><given-names>L. S.</given-names></name></person-group> (<year>2002</year>). <article-title>AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling</article-title>. <source>J. Biol. Chem.</source>
<volume>277</volume>, <fpage>23977</fpage>&#x02013;<lpage>23980</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.C200171200</pub-id><pub-id pub-id-type="pmid">11997383</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>F. W.</given-names></name><name><surname>Gordon</surname><given-names>S. E.</given-names></name><name><surname>Carlson</surname><given-names>C. J.</given-names></name><name><surname>Hamilton</surname><given-names>M. T.</given-names></name></person-group> (<year>2000</year>). <article-title>Waging war on modern chronic diseases: primary prevention through exercise biology</article-title>. <source>J. Appl. Physiol. (1985).</source>
<volume>88</volume>, <fpage>774</fpage>&#x02013;<lpage>787</lpage>. <pub-id pub-id-type="pmid">10658050</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>L. M.</given-names></name><name><surname>van Loon</surname><given-names>L. J.</given-names></name><name><surname>Hawley</surname><given-names>J. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Post-exercise muscle glycogen resynthesis in humans</article-title>. <source>J. Appl. Physiol. (1985)</source>
<volume>122</volume>, <fpage>1055</fpage>&#x02013;<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00860.2016</pub-id><pub-id pub-id-type="pmid">27789774</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnett</surname><given-names>P. E.</given-names></name><name><surname>Barrow</surname><given-names>R. K.</given-names></name><name><surname>Cohen</surname><given-names>N. A.</given-names></name><name><surname>Snyder</surname><given-names>S. H.</given-names></name><name><surname>Sabatini</surname><given-names>D. M.</given-names></name></person-group> (<year>1998</year>). <article-title>RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>95</volume>, <fpage>1432</fpage>&#x02013;<lpage>1437</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.4.1432</pub-id><pub-id pub-id-type="pmid">9465032</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname><given-names>G. F.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2006</year>). <article-title>Fuel metabolism in starvation</article-title>. <source>Annu. Rev. Nutr.</source>
<volume>26</volume>, <fpage>1</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.nutr.26.061505.111258</pub-id><pub-id pub-id-type="pmid">16848698</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname><given-names>G. F.</given-names><suffix>Jr.</suffix></name><name><surname>Veech</surname><given-names>R. L.</given-names></name></person-group> (<year>2003</year>). <article-title>Ketoacids? Good medicine?</article-title>
<source>Trans. Am. Clin. Climatol. Assoc</source>. <volume>114</volume>, <fpage>149</fpage>&#x02013;<lpage>161</lpage>. discussion: 62&#x02013;63. <pub-id pub-id-type="pmid">12813917</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Churchward-Venne</surname><given-names>T. A.</given-names></name><name><surname>Burd</surname><given-names>N. A.</given-names></name><name><surname>Phillips</surname><given-names>S. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Nutritional regulation of muscle protein synthesis with resistance exercise: strategies to enhance anabolism</article-title>. <source>Nutr. Metab. (Lond).</source>
<volume>9</volume>:<fpage>40</fpage>. <pub-id pub-id-type="doi">10.1186/1743-7075-9-40</pub-id><pub-id pub-id-type="pmid">22594765</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>K.</given-names></name><name><surname>Tchabanenko</surname><given-names>K.</given-names></name><name><surname>Pawlosky</surname><given-names>R.</given-names></name><name><surname>Carter</surname><given-names>E.</given-names></name><name><surname>Knight</surname><given-names>N. S.</given-names></name><name><surname>Murray</surname><given-names>A. J.</given-names></name><etal/></person-group>. (<year>2012a</year>). <article-title>Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate</article-title>. <source>Regul. Toxicol. Pharmacol.</source>
<volume>63</volume>, <fpage>196</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.yrtph.2012.04.001</pub-id><pub-id pub-id-type="pmid">22504461</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>K.</given-names></name><name><surname>Tchabanenko</surname><given-names>K.</given-names></name><name><surname>Pawlosky</surname><given-names>R.</given-names></name><name><surname>Carter</surname><given-names>E.</given-names></name><name><surname>Todd King</surname><given-names>M.</given-names></name><name><surname>Musa-Veloso</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2012b</year>). <article-title>Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects</article-title>. <source>Regul. Toxicol. Pharmacol.</source>
<volume>63</volume>, <fpage>401</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1016/j.yrtph.2012.04.008</pub-id><pub-id pub-id-type="pmid">22561291</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costill</surname><given-names>D. L.</given-names></name><name><surname>Sherman</surname><given-names>W. M.</given-names></name><name><surname>Fink</surname><given-names>W. J.</given-names></name><name><surname>Maresh</surname><given-names>C.</given-names></name><name><surname>Witten</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>J. M.</given-names></name></person-group> (<year>1981</year>). <article-title>The role of dietary carbohydrates in muscle glycogen resynthesis after strenuous running</article-title>. <source>Am. J. Clin. Nutr.</source>
<volume>34</volume>, <fpage>1831</fpage>&#x02013;<lpage>1836</lpage>. <pub-id pub-id-type="pmid">7282610</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>P. J.</given-names></name><name><surname>Clarke</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Acute nutritional ketosis: implications for exercise performance and metabolism</article-title>. <source>Extrem. Physiol. Med.</source>
<volume>3</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.1186/2046-7648-3-17</pub-id><pub-id pub-id-type="pmid">25379174</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>P. J.</given-names></name><name><surname>Kirk</surname><given-names>T.</given-names></name><name><surname>Ashmore</surname><given-names>T.</given-names></name><name><surname>Willerton</surname><given-names>K.</given-names></name><name><surname>Evans</surname><given-names>R.</given-names></name><name><surname>Smith</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Nutritional ketosis alters fuel preference and thereby endurance performance in athletes</article-title>. <source>Cell Metab.</source>
<volume>24</volume>, <fpage>256</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.07.010</pub-id><pub-id pub-id-type="pmid">27475046</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dreyer</surname><given-names>H. C.</given-names></name><name><surname>Fujita</surname><given-names>S.</given-names></name><name><surname>Cadenas</surname><given-names>J. G.</given-names></name><name><surname>Chinkes</surname><given-names>D. L.</given-names></name><name><surname>Volpi</surname><given-names>E.</given-names></name><name><surname>Rasmussen</surname><given-names>B. B.</given-names></name></person-group> (<year>2006</year>). <article-title>Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle</article-title>. <source>J. Physiol. (Lond).</source>
<volume>576</volume>, <fpage>613</fpage>&#x02013;<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2006.113175</pub-id><pub-id pub-id-type="pmid">16873412</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>M. J.</given-names></name><name><surname>Dreyer</surname><given-names>H. C.</given-names></name><name><surname>Fry</surname><given-names>C. S.</given-names></name><name><surname>Glynn</surname><given-names>E. L.</given-names></name><name><surname>Rasmussen</surname><given-names>B. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling</article-title>. <source>J. Appl. Physiol. (1985)</source>
<volume>106</volume>, <fpage>1374</fpage>&#x02013;<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.91397.2008</pub-id><pub-id pub-id-type="pmid">19150856</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>B.</given-names></name><name><surname>D'Agostino</surname><given-names>D. P.</given-names></name></person-group> (<year>2016</year>). <article-title>Fueling performance: ketones enter the mix</article-title>. <source>Cell Metab.</source>
<volume>24</volume>, <fpage>373</fpage>&#x02013;<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.08.021</pub-id><pub-id pub-id-type="pmid">27626197</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>B.</given-names></name><name><surname>Zierath</surname><given-names>J. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Exercise metabolism and the molecular regulation of skeletal muscle adaptation</article-title>. <source>Cell Metab.</source>
<volume>17</volume>, <fpage>162</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2012.12.012</pub-id><pub-id pub-id-type="pmid">23395166</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floyd</surname><given-names>J. C.</given-names><suffix>Jr.</suffix></name><name><surname>Fajans</surname><given-names>S. S.</given-names></name><name><surname>Pek</surname><given-names>S.</given-names></name><name><surname>Thiffault</surname><given-names>C. A.</given-names></name><name><surname>Knopf</surname><given-names>R. F.</given-names></name><name><surname>Conn</surname><given-names>J. W.</given-names></name></person-group> (<year>1970</year>). <article-title>Synergistic effect of essential amino acids and glucose upon insulin secretion in man</article-title>. <source>Diabetes</source>
<volume>19</volume>, <fpage>109</fpage>&#x02013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.2337/diab.19.2.109</pub-id><pub-id pub-id-type="pmid">4905636</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>J. T.</given-names></name><name><surname>Fuchs</surname><given-names>C. J.</given-names></name><name><surname>Betts</surname><given-names>J. A.</given-names></name><name><surname>van Loon</surname><given-names>L. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Liver glycogen metabolism during and after prolonged endurance-type exercise</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source>
<volume>311</volume>, <fpage>E543</fpage>&#x02013;<lpage>E553</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00232.2016</pub-id><pub-id pub-id-type="pmid">27436612</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>C. A.</given-names></name><name><surname>Mabrey</surname><given-names>D. M.</given-names></name><name><surname>Frey</surname><given-names>J. W.</given-names></name><name><surname>Miu</surname><given-names>M. H.</given-names></name><name><surname>Schmidt</surname><given-names>E. K.</given-names></name><name><surname>Pierre</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive <italic>in vivo</italic> technique</article-title>. <source>FASEB J.</source>
<volume>25</volume>, <fpage>1028</fpage>&#x02013;<lpage>1039</lpage>. <pub-id pub-id-type="doi">10.1096/fj.10-168799</pub-id><pub-id pub-id-type="pmid">21148113</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhaff</surname><given-names>P. L.</given-names></name><name><surname>Karagounis</surname><given-names>L. G.</given-names></name><name><surname>Peirce</surname><given-names>N.</given-names></name><name><surname>Simpson</surname><given-names>E. J.</given-names></name><name><surname>Hazell</surname><given-names>M.</given-names></name><name><surname>Layfield</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source>
<volume>295</volume>, <fpage>E595</fpage>&#x02013;<lpage>E604</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.90411.2008</pub-id><pub-id pub-id-type="pmid">18577697</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwinn</surname><given-names>D. M.</given-names></name><name><surname>Shackelford</surname><given-names>D. B.</given-names></name><name><surname>Egan</surname><given-names>D. F.</given-names></name><name><surname>Mihaylova</surname><given-names>M. M.</given-names></name><name><surname>Mery</surname><given-names>A.</given-names></name><name><surname>Vasquez</surname><given-names>D. S.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>AMPK phosphorylation of raptor mediates a metabolic checkpoint</article-title>. <source>Mol. Cell</source>
<volume>30</volume>, <fpage>214</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2008.03.003</pub-id><pub-id pub-id-type="pmid">18439900</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardie</surname><given-names>D. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism</article-title>. <source>Proc. Nutr. Soc.</source>
<volume>70</volume>, <fpage>92</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1017/S0029665110003915</pub-id><pub-id pub-id-type="pmid">21067629</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawley</surname><given-names>J. A.</given-names></name><name><surname>Burke</surname><given-names>L. M.</given-names></name><name><surname>Phillips</surname><given-names>S. M.</given-names></name><name><surname>Spriet</surname><given-names>L. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Nutritional modulation of training-induced skeletal muscle adaptations</article-title>. <source>J. Appl. Physiol. (1985)</source>
<volume>110</volume>, <fpage>834</fpage>&#x02013;<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00949.2010</pub-id><pub-id pub-id-type="pmid">21030665</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawley</surname><given-names>J. A.</given-names></name><name><surname>Schabort</surname><given-names>E. J.</given-names></name><name><surname>Noakes</surname><given-names>T. D.</given-names></name><name><surname>Dennis</surname><given-names>S. C.</given-names></name></person-group> (<year>1997</year>). <article-title>Carbohydrate-loading and exercise performance. An update</article-title>. <source>Sports Med.</source>
<volume>24</volume>, <fpage>73</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.2165/00007256-199724020-00001</pub-id><pub-id pub-id-type="pmid">9291549</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hespel</surname><given-names>P. B.</given-names></name><name><surname>Opt</surname><given-names>E.</given-names></name><name><surname>Van Leemputte</surname><given-names>M.</given-names></name><name><surname>Urso</surname><given-names>B.</given-names></name><name><surname>Greenhaff</surname><given-names>P. L.</given-names></name><name><surname>Labarque</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans</article-title>. <source>J. Physiol.</source>
<volume>536</volume>, <fpage>625</fpage>&#x02013;<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.2001.0625c.xd</pub-id><pub-id pub-id-type="pmid">11600695</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holdsworth</surname><given-names>D.</given-names></name><name><surname>Cox</surname><given-names>P. J.</given-names></name><name><surname>Clarke</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Oral ketone body supplementation accelerates and enhances glycogen synthesis in human skeletal muscle following exhaustive exercise</article-title>. <source>Proc. Physiol. Soc.</source>
<fpage>35</fpage>.</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Impey</surname><given-names>S. G.</given-names></name><name><surname>Hammond</surname><given-names>K. M.</given-names></name><name><surname>Shepherd</surname><given-names>S. O.</given-names></name><name><surname>Sharples</surname><given-names>A. P.</given-names></name><name><surname>Stewart</surname><given-names>C.</given-names></name><name><surname>Limb</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Fuel for the work required: a practical approach to amalgamating train-low paradigms for endurance athletes</article-title>. <source>Physiol Rep</source>. <volume>4</volume>:<fpage>e12803</fpage>. <pub-id pub-id-type="doi">10.14814/phy2.12803</pub-id><pub-id pub-id-type="pmid">27225627</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>T. E.</given-names></name><name><surname>Richter</surname><given-names>E. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Regulation of glucose and glycogen metabolism during and after exercise</article-title>. <source>J. Physiol. (Lond).</source>
<volume>590</volume>, <fpage>1069</fpage>&#x02013;<lpage>1076</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2011.224972</pub-id><pub-id pub-id-type="pmid">22199166</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashiwaya</surname><given-names>Y.</given-names></name><name><surname>Pawlosky</surname><given-names>R.</given-names></name><name><surname>Markis</surname><given-names>W.</given-names></name><name><surname>King</surname><given-names>M. T.</given-names></name><name><surname>Bergman</surname><given-names>C.</given-names></name><name><surname>Srivastava</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat</article-title>. <source>J. Biol. Chem.</source>
<volume>285</volume>, <fpage>25950</fpage>&#x02013;<lpage>25956</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.138198</pub-id><pub-id pub-id-type="pmid">20529850</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koeslag</surname><given-names>J. H.</given-names></name></person-group> (<year>1982</year>). <article-title>Post-exercise ketosis and the hormone response to exercise: a review</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>14</volume>, <fpage>327</fpage>&#x02013;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1249/00005768-198205000-00003</pub-id><pub-id pub-id-type="pmid">6759842</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lowry</surname><given-names>O. H.</given-names></name><name><surname>Passonneau</surname><given-names>J. V.</given-names></name></person-group> (<year>1972</year>). <source>A Flexible System of Enzymatic Analysis</source> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Academic Press</publisher-name>).</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madison</surname><given-names>L. L.</given-names></name><name><surname>Mebane</surname><given-names>D.</given-names></name><name><surname>Unger</surname><given-names>R. H.</given-names></name><name><surname>Lochner</surname><given-names>A.</given-names></name></person-group> (<year>1964</year>). <article-title>The hypoglycemic action of ketones. Ii. evidence for a stimulatory feedback of ketones on the pancreatic beta cells</article-title>. <source>J. Clin. Invest.</source>
<volume>43</volume>, <fpage>408</fpage>&#x02013;<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1172/JCI104925</pub-id><pub-id pub-id-type="pmid">14135491</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maizels</surname><given-names>E. Z.</given-names></name><name><surname>Ruderman</surname><given-names>N. B.</given-names></name><name><surname>Goodman</surname><given-names>M. N.</given-names></name><name><surname>Lau</surname><given-names>D.</given-names></name></person-group> (<year>1977</year>). <article-title>Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat</article-title>. <source>Biochem. J.</source>
<volume>162</volume>, <fpage>557</fpage>&#x02013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1042/bj1620557</pub-id><pub-id pub-id-type="pmid">869905</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marabita</surname><given-names>M.</given-names></name><name><surname>Baraldo</surname><given-names>M.</given-names></name><name><surname>Solagna</surname><given-names>F.</given-names></name><name><surname>Ceelen</surname><given-names>J. J.</given-names></name><name><surname>Sartori</surname><given-names>R.</given-names></name><name><surname>Nolte</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>S6K1 is required for increasing skeletal muscle force during hypertrophy</article-title>. <source>Cell Rep.</source>
<volume>17</volume>, <fpage>501</fpage>&#x02013;<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.020</pub-id><pub-id pub-id-type="pmid">27705797</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masschelein</surname><given-names>E.</given-names></name><name><surname>Van Thienen</surname><given-names>R.</given-names></name><name><surname>D'Hulst</surname><given-names>G.</given-names></name><name><surname>Hespel</surname><given-names>P.</given-names></name><name><surname>Thomis</surname><given-names>M.</given-names></name><name><surname>Deldicque</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Acute environmental hypoxia induces LC3 lipidation in a genotype-dependent manner</article-title>. <source>FASEB J.</source>
<volume>28</volume>, <fpage>1022</fpage>&#x02013;<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1096/fj.13-239863</pub-id><pub-id pub-id-type="pmid">24200883</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morton</surname><given-names>R. W.</given-names></name><name><surname>McGlory</surname><given-names>C.</given-names></name><name><surname>Phillips</surname><given-names>S. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Nutritional interventions to augment resistance training-induced skeletal muscle hypertrophy</article-title>. <source>Front. Physiol.</source>
<volume>6</volume>:<fpage>245</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2015.00245</pub-id><pub-id pub-id-type="pmid">26388782</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>A. J.</given-names></name><name><surname>Knight</surname><given-names>N. S.</given-names></name><name><surname>Cole</surname><given-names>M. A.</given-names></name><name><surname>Cochlin</surname><given-names>L. E.</given-names></name><name><surname>Carter</surname><given-names>E.</given-names></name><name><surname>Tchabanenko</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Novel ketone diet enhances physical and cognitive performance</article-title>. <source>FASEB J.</source>
<volume>30</volume>, <fpage>4021</fpage>&#x02013;<lpage>4032</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201600773R</pub-id><pub-id pub-id-type="pmid">27528626</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>K. S.</given-names></name><name><surname>Welle</surname><given-names>S. L.</given-names></name><name><surname>Halliday</surname><given-names>D.</given-names></name><name><surname>Campbell</surname><given-names>R. G.</given-names></name></person-group> (<year>1988</year>). <article-title>Effect of beta-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans</article-title>. <source>J. Clin. Invest.</source>
<volume>82</volume>, <fpage>198</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1172/JCI113570</pub-id><pub-id pub-id-type="pmid">3392207</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatani</surname><given-names>K.</given-names></name><name><surname>Watabe</surname><given-names>T.</given-names></name><name><surname>Masuda</surname><given-names>D.</given-names></name><name><surname>Imaizumi</surname><given-names>M.</given-names></name><name><surname>Shimosegawa</surname><given-names>E.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Myocardial energy provision is preserved by increased utilization of glucose and ketone bodies in CD36 knockout mice</article-title>. <source>Metab. Clin. Exp.</source>
<volume>64</volume>, <fpage>1165</fpage>&#x02013;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2015.05.017</pub-id><pub-id pub-id-type="pmid">26130608</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>O. E.</given-names></name></person-group> (<year>2005</year>). <article-title>Ketone bodies as a fuel for the brain during starvation</article-title>. <source>Biochem. Mol. Biol. Educ.</source>
<volume>33</volume>, <fpage>246</fpage>&#x02013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1002/bmb.2005.49403304246</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>B.</given-names></name><name><surname>Cotterill</surname><given-names>A.</given-names></name><name><surname>Grathwohl</surname><given-names>D.</given-names></name><name><surname>Stellingwerff</surname><given-names>T.</given-names></name><name><surname>Jeukendrup</surname><given-names>A. E.</given-names></name></person-group> (<year>2009</year>). <article-title>The effect of carbohydrate gels on gastrointestinal tolerance during a 16-km run</article-title>. <source>Int. J. Sport Nutr. Exerc. Metab.</source>
<volume>19</volume>, <fpage>485</fpage>&#x02013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1123/ijsnem.19.5.485</pub-id><pub-id pub-id-type="pmid">19910651</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phinney</surname><given-names>S. D.</given-names></name><name><surname>Bistrian</surname><given-names>B. R.</given-names></name><name><surname>Wolfe</surname><given-names>R. R.</given-names></name><name><surname>Blackburn</surname><given-names>G. L.</given-names></name></person-group> (<year>1983</year>). <article-title>The human metabolic response to chronic ketosis without caloric restriction: physical and biochemical adaptation</article-title>. <source>Metab. Clin. Exp.</source>
<volume>32</volume>, <fpage>757</fpage>&#x02013;<lpage>768</lpage>. <pub-id pub-id-type="doi">10.1016/0026-0495(83)90105-1</pub-id><pub-id pub-id-type="pmid">6865775</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinckaers</surname><given-names>P. J.</given-names></name><name><surname>Churchward-Venne</surname><given-names>T. A.</given-names></name><name><surname>Bailey</surname><given-names>D.</given-names></name><name><surname>van Loon</surname><given-names>L. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Ketone bodies and exercise performance: the next magic bullet or merely hype?</article-title>
<source>Sports Med</source>. <volume>47</volume>, <fpage>383</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-016-0577-y</pub-id><pub-id pub-id-type="pmid">27430501</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiaffino</surname><given-names>S.</given-names></name><name><surname>Mammucari</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models</article-title>. <source>Skelet. Muscle</source>
<volume>1</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/2044-5040-1-4</pub-id><pub-id pub-id-type="pmid">21798082</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherwin</surname><given-names>R. S.</given-names></name><name><surname>Hendler</surname><given-names>R. G.</given-names></name><name><surname>Felig</surname><given-names>P.</given-names></name></person-group> (<year>1975</year>). <article-title>Effect of ketone infusions on amino acid and nitrogen metabolism in man</article-title>. <source>J. Clin. Invest.</source>
<volume>55</volume>, <fpage>1382</fpage>&#x02013;<lpage>1390</lpage>. <pub-id pub-id-type="doi">10.1172/JCI108057</pub-id><pub-id pub-id-type="pmid">1133179</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Tu</surname><given-names>B. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Acetyl-CoA and the regulation of metabolism: mechanisms and consequences</article-title>. <source>Curr. Opin. Cell Biol.</source>
<volume>33</volume>, <fpage>125</fpage>&#x02013;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceb.2015.02.003</pub-id><pub-id pub-id-type="pmid">25703630</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terzis</surname><given-names>G.</given-names></name><name><surname>Georgiadis</surname><given-names>G.</given-names></name><name><surname>Stratakos</surname><given-names>G.</given-names></name><name><surname>Vogiatzis</surname><given-names>I.</given-names></name><name><surname>Kavouras</surname><given-names>S.</given-names></name><name><surname>Manta</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Resistance exercise-induced increase in muscle mass correlates with p70S6 kinase phosphorylation in human subjects</article-title>. <source>Eur. J. Appl. Physiol.</source>
<volume>102</volume>, <fpage>145</fpage>&#x02013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1007/s00421-007-0564-y</pub-id><pub-id pub-id-type="pmid">17874120</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>D. M.</given-names></name><name><surname>Fick</surname><given-names>C. A.</given-names></name><name><surname>Gordon</surname><given-names>S. E.</given-names></name></person-group> (<year>2008</year>). <article-title>AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions</article-title>. <source>J. Appl. Physiol. (1985)</source>
<volume>104</volume>, <fpage>625</fpage>&#x02013;<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00915.2007</pub-id><pub-id pub-id-type="pmid">18187610</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tischler</surname><given-names>M. E.</given-names></name><name><surname>Desautels</surname><given-names>M.</given-names></name><name><surname>Goldberg</surname><given-names>A. L.</given-names></name></person-group> (<year>1982</year>). <article-title>Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle?</article-title>
<source>J. Biol. Chem.</source>
<volume>257</volume>, <fpage>1613</fpage>&#x02013;<lpage>1621</lpage>. <pub-id pub-id-type="pmid">6915936</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Thienen</surname><given-names>R.</given-names></name><name><surname>D'Hulst</surname><given-names>G.</given-names></name><name><surname>Deldicque</surname><given-names>L.</given-names></name><name><surname>Hespel</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Biochemical artifacts in experiments involving repeated biopsies in the same muscle</article-title>. <source>Physiol. Rep.</source>
<volume>2</volume>:<fpage>e00286</fpage>. <pub-id pub-id-type="doi">10.14814/phy2.286</pub-id><pub-id pub-id-type="pmid">24819751</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volek</surname><given-names>J. S.</given-names></name><name><surname>Freidenreich</surname><given-names>D. J.</given-names></name><name><surname>Saenz</surname><given-names>C.</given-names></name><name><surname>Kunces</surname><given-names>L. J.</given-names></name><name><surname>Creighton</surname><given-names>B. C.</given-names></name><name><surname>Bartley</surname><given-names>J. M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Metabolic characteristics of keto-adapted ultra-endurance runners</article-title>. <source>Metabolism</source>
<volume>65</volume>, <fpage>100</fpage>&#x02013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2015.10.028</pub-id><pub-id pub-id-type="pmid">26892521</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Thompson</surname><given-names>J. R.</given-names></name></person-group> (<year>1990</year>). <article-title>The effect of ketone bodies on protein turnover in isolated skeletal muscle from the fed and fasted chick</article-title>. <source>Int. J. Biochem.</source>
<volume>22</volume>, <fpage>263</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/0020-711X(90)90338-4</pub-id><pub-id pub-id-type="pmid">2332105</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zurlo</surname><given-names>F.</given-names></name><name><surname>Nemeth</surname><given-names>P. M.</given-names></name><name><surname>Choksi</surname><given-names>R. M.</given-names></name><name><surname>Sesodia</surname><given-names>S.</given-names></name><name><surname>Ravussin</surname><given-names>E.</given-names></name></person-group> (<year>1994</year>). <article-title>Whole-body energy metabolism and skeletal muscle biochemical characteristics</article-title>. <source>Metabolism</source>
<volume>43</volume>, <fpage>481</fpage>&#x02013;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1016/0026-0495(94)90081-7</pub-id><pub-id pub-id-type="pmid">8159108</pub-id></mixed-citation></ref></ref-list><glossary><def-list><title>Abbreviations</title><def-item><term>AcAc</term><def><p>aceto-acetate</p></def></def-item><def-item><term>AMPK</term><def><p>AMP-activated protein kinase</p></def></def-item><def-item><term>BSA</term><def><p>bovine serum albumin</p></def></def-item><def-item><term>&#x003b2;HB</term><def><p>beta-hydroxybutyrate</p></def></def-item><def-item><term>BW</term><def><p>body weight</p></def></def-item><def-item><term>DMEM</term><def><p>Dulbecco's Modified Eagle Medium</p></def></def-item><def-item><term>4E-BP1</term><def><p>eukaryotic initiation factor 4E-binding protein 1</p></def></def-item><def-item><term>KB</term><def><p>ketone bodies</p></def></def-item><def-item><term>KE</term><def><p>ketone ester [(R)-3-hydroxybutyl (R)-3-hydroxybutyrate]</p></def></def-item><def-item><term>mM</term><def><p>millimolar</p></def></def-item><def-item><term>mTORC1</term><def><p>mechanistic target of rapamycin complex 1</p></def></def-item><def-item><term>PL</term><def><p>placebo</p></def></def-item><def-item><term>1RM</term><def><p>one-repetition max</p></def></def-item><def-item><term>S6K1</term><def><p>p70 ribosomal S6 kinase 1</p></def></def-item><def-item><term>TBS-T</term><def><p>tris-buffered saline with Tween-20</p></def></def-item><def-item><term>TCA</term><def><p>tricarboxylic acid cycle</p></def></def-item><def-item><term>TSC2</term><def><p>tuberous sclerosis complex 2</p></def></def-item><def-item><term>kDa</term><def><p>kilodalton.</p></def></def-item></def-list></glossary></back></article>